PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jorthsurgBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleJournal of Orthopaedic Surgery and ResearchJournal Front Page
 
J Orthop Surg Res. 2017; 12: 37.
Published online 2017 March 3. doi:  10.1186/s13018-017-0539-6
PMCID: PMC5335822

Evaluation of Singh Index and Osteoporosis Self-Assessment Tool for Asians as risk assessment tools of hip fracture in patients with type 2 diabetes mellitus

Abstract

Background

Type 2 diabetes mellitus (T2DM), an epidemic disease around world, has recently been identified as a risk factor for osteoporosis-associated fracture. However, there is no consensus on the best method of assessing fracture risk in patients with T2DM. The aim of this study was to evaluate the usefulness of the Osteoporosis Self-Assessment Tool for Asians (OSTA) and the Singh Index (SI) in hip fracture risk assessment in patients with T2DM.

Methods

We enrolled 261 postmenopausal women with T2DM: 87 had hip fracture resulting from low-energy trauma and 174 age-matched controls had no fracture (two controls per fracture case). Bone mineral density (BMD) was measured with dual-energy X-ray absorptiometry in the lumbar spine and hip region. The SI was obtained from standard antero-posterior radiographs of the pelvis. The OSTA was calculated with a formula based on weight and age. Data were analyzed with descriptive statistics and tests of difference. Receiver operating characteristic analysis was used to determine optimum cutoff values, sensitivity, and specificity of screening methods. Discriminative abilities of different screening tools were compared with the area under the curve (AUC).

Results

There were significant differences in BMD at all sites (lumbar spine, femoral neck, trochanter, and total hip) and in SI between the fracture and non-fracture groups (P < 0.05). There was no significant difference in OSTA between the groups (P > 0.05). The area under the curve was 0.747 (95% CI: 0.680–0.813) for lumbar spine BMD, 0.699 (95% CI: 0.633–0.764) for total hip BMD, 0.659 (95% CI: 0.589–0.729) for femoral neck BMD, 0.631 (95% CI: 0.557–0.704) for trochanter BMD, 0.534 (95% CI: 0.459–0.610) for OSTA, 0.636 (95% CI: 0.564–0.709) for SI, and 0.795 (95% CI: 0.734–0.857) for OSTA plus SI. The AUC for combined OSTA plus SI was significantly superior to other parameters besides BMD of the lumbar spine.

Conclusions

The combination of OSTA plus SI could be a clinical alternative tool for screening of hip fracture risk in large diabetic populations. These tests are inexpensive and simple to perform and could be especially useful in areas where BMD measurement is not accessible.

Keywords: Hip fracture, Self-Assessment Tool for Asians, Singh Index, Type 2 diabetes mellitus

Background

Diabetes mellitus is an epidemic disease associated with substantial comorbidity. The number of people with type 2 diabetes mellitus (T2DM) is expected to steadily increase worldwide [1]. T2DM has recently been identified as an important risk factor for osteoporosis-associated fracture, depending on skeletal site and disease severity [24]. Bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) is recognized as a major tool to detect osteoporosis and predict fracture risk. However, because of the complex pathophysiology of T2DM, BMD studies in diabetic patients have shown contradictory results, including normal, reduced, and increased BMD [58]. As a result of this controversy, there is no consensus on the best method of assessing fracture risk in patients with T2DM [911].

The Singh Index (SI) is a simple, semiquantitative evaluation tool for diagnosing osteoporosis with plain radiographs [12]. The SI is based on the trabecular pattern of the proximal femur and classifies osteoporosis into six grades. This method is available for routine use and mass screening because plain films can be obtained at most outpatient clinics. Several studies have confirmed that the SI is an effective tool to assess proximal femoral bone strength [1315]. However, the reliability and accuracy of the SI remain controversial compared with BMD assessment. In addition, the SI was proposed to contain independent information about osteoporosis, which might reflect structural integrity in trabecular bone [13, 16, 17]. Several studies have suggested that a combination of reduced bone mass and altered bone quality, which are not assessed with BMD alone, are important risk factors for fracture in diabetic patients [18, 19]. Therefore, SI may be used as a screening tool to help clinicians identify patients at increased fracture risk.

The Osteoporosis Self-Assessment Tool for Asians (OSTA) has been developed to discriminate patients with high osteoporosis risk for BMD measurement by using a formula [20, 21]. In previous studies, the OSTA has been shown to effectively predict osteoporosis risk and to determine appropriate use of BMD testing in Asian countries without sufficient DXA equipment [2225]. A few studies have also demonstrated that OSTA may help to identify fracture risk among postmenopausal women [2628]. Based on a study in eight Asian countries, the OSTA index uses only age and weight from among 11 risk factors to classify the risk of osteoporosis [29]. Because T2DM is associated with increased body weight, the OSTA may underestimate fracture risk in diabetic patients and its validity in these patients remains unknown.

With current demographic changes, physicians will need to treat an increasing number of diabetic patients at a higher risk of osteoporosis. Hip fracture is the most devastating consequence of osteoporosis, with high morbidity, mortality, and economic burden. However, DXA scans are not available to evaluate bone health at all healthcare centers because this diagnostic method is expensive and complicated. Thus, clinicians need a simple and inexpensive screening method to discriminate those patients at high risk of hip fracture from among the large number of patients with diabetes. In the present analysis, we investigated the discriminative ability of OSTA and SI alone and in combination in predicting hip fracture risk in T2DM patients. We sought an alternative method of identifying those diabetic patients at risk for hip fracture in daily clinical practice.

Methods

This retrospective study was conducted at a single university teaching center. Postmenopausal women with T2DM and femoral neck or intertrochanteric fracture resulting from low-energy trauma were retrospectively recruited from 2009 to 2015. Patients who had undergone BMD measurement of the spine and of the hip contralateral to the fracture site at the time of fracture were eligible for inclusion. Control cases were selected from our pool of patients with BMD testing results and medical records. For every patient with hip fracture, we included two matched controls with T2DM, age ± 2 years, and no low-energy fracture. Exclusion criteria for all participants were the following: (1) any treatment or illness that would affect bone metabolism, (2) history of any spinal surgery, and (3) severe scoliosis or degenerative lumbar disease that would affect BMD measurement.

In all cases, T2DM was diagnosed on the basis of medical records and questionnaire. If a diabetes diagnosis was made during the 5 years prior to BMD testing, the T2DM status was confirmed. Body mass index (BMI) was calculated with the following standard formula: BMI = weight (kg)/height (m)2.

BMD measurements

BMD testing was performed with a single DXA scanner (Discovery W; Hologic, Inc., Bedford, MA, USA). An anatomical spine phantom was measured daily for quality control at our institution. The coefficient of variation of the technique was 0.8%, indicating stable results. Every participant had BMD measured at the left hip and at the lumbar spine from L1 to L4. In patients with hip fracture, BMD was measured on the contralateral hip. All BMD measurements were made by two experienced technicians. The scanning procedures and analysis were performed according to the standard manual supplied by the manufacturer. BMD was calculated on the basis of normal reference values for the Chinese population, in accordance with manufacturer recommendations. T-scores were used to express BMD. BMD was classified based on the World Health Organization criteria: T-score ≤−2.5 SD, osteoporotic; T-score >−2.5 and <−1.0 SD, osteopenic; T-score ≥−1.0, normal.

OSTA calculation

The OSTA index was calculated with the following formula: [body weight (kg)  age (years)] × 0.2. Digits after the decimal point were disregarded. The OSTA values were classified as follows: <−4, high risk; −4 to −1, intermediate risk; >−1, low risk.

Evaluation of the Singh Index

Standard digital antero-posterior radiographs of the pelvis in the supine position were obtained to assess the SI. According to the Singh criteria, SI scores ranged from 1 (severe osteoporosis) to 6 (normal bone density). SI was assessed in the proximal femur on the same side used for BMD measurement. All radiographs were evaluated by a single observer.

The following parameters were collected for each participant: patient age, weight, height, BMI, fracture site, BMD, OSTA, and SI.

Statistical analysis

Statistical analyses were performed with SSPS software 18.0 (SPSS, Chicago, IL, USA). Descriptive statistics are expressed as mean ± standard deviation (SD). Intergroup differences were assessed with Student’s t test or analysis of covariances when adjusted for confounding factors, depending on the distribution normality of the tested parameter. P values <0.05 were considered statistically significant. The diagnostic value of each parameter was evaluated with the area under the receiving operator curve (ROC; AUC: area under the curve). Ninety-five percent confidence intervals of the AUC were calculated.

Results

The final study population included 261 women, 87 with hip fracture and 174 controls without hip fracture. In the hip fracture group, 66.7% (58/87) had a T-score lower than −2.5 SD; in the control group, only 41.4% (72/174) had a T-score lower than −2.5 SD. Descriptive statistics of the study population are presented in Table 1.

Table 1
Characteristics of patients with fracture in comparison to those without fracture

Comparison between participants with and without fracture

There were no significant differences between the fracture and non-fracture groups in mean age (74.0 vs. 73.9 years, P = 0.879), height (157.1 vs. 156.5 cm, P = 0.897), weight (60.8 vs. 62.4 kg, P = 0.135), BMI (24.7 vs. 25.5 kg/cm2, P = 0.103), or OSTA scores (−2.3 vs. −2.0, P = 0.208). All BMD parameters at the lumbar spine and hip region (including total hip, femoral neck, and trochanter regions) were notably lower in the fracture group than in the non-fracture group, (−2.2 vs. −1.2, P < 0.0001 for lumbar spine; −2.6 vs. −1.6, P < 0.0001 for total hip; −2.7 vs. −2.0, P < 0.0001 for femoral neck; −2.3 vs. −1.6, P < 0.0001 for trochanter). In addition, SI scores were lower in the fracture group than in the non-fracture group (3.4 vs. 3.7, P = 0.017). All BMD parameters and SI scores remained significantly different when adjusted for BMI with covariance. Results are presented in Table 1.

ROC curve

With regard to hip fracture, the screening test performance characteristics and ROC curves are shown in Table 2 and Fig. 1. The AUC was 0.534 (95% CI: 0.459–0.610) for the OSTA, 0.636 (95% CI: 0.564–0.709) for the SI, 0.747 (95% CI: 0.680–0.813) for lumbar spine BMD, 0.699 (95% CI: 0.633–0.764) for total hip BMD, 0.659 (95% CI: 0.589–0.729) for femoral neck BMD, and 0.631 (95% CI: 0.557–0.704) for trochanter BMD. The cutoffs were −2.5, 2.5, −1.85, −2.45, −2.05, and −2.25, respectively. Furthermore, the optimal cutoff point as defined with the Youden index (sensitivity + specificity  1) yielded the maximum value. AUCs of these parameters from high to low were BMD (lumbar spine), BMD (total hip), BMD (trochanter), SI, BMD (femoral neck), and OSTA. Next, the OSTA plus SI combination model was obtained using a logistic regression process. The AUC of the combination of OSTA plus SI was 0.795 (95% CI: 0.734–0.857). The combination of OSTA plus SI was compared with other screening methods. The AUC for combined OSTA plus SI was significantly different from that of OSTA alone (95% CI: 0.173–0.349, Z = 5.817, P < 0.0001), SI alone (95% CI: 0.086–0.232, Z = 4.254, P < 0.0001), BMD of total hip (95% CI: 0.017–0.177, Z = 2.368, P = 0.0179), BMD of trochanter (95% CI: 0.084–0.246, Z = 3.982, P = 0.0001), and BMD of femoral neck (95% CI: 0.086–0.232, Z = 4.254, P < 0.0001). However, the combination was not significantly superior to BMD of the lumbar spine (95% CI: −0.027–0.125, Z = 1.258, P = 0.2084).

Table 2
ROC analysis of diagnostic performance characteristics of BMD, OSTA, and SI
Fig. 1
The ROC curves for BMD

Discussion

In this study, we evaluated the potential predictive value of the SI, OSTA, and of the combination of SI and OSTA in differentiating diabetic women with hip fracture from those without hip fracture. We found that the combination of SI plus OSTA and BMD of the lumbar spine performed better than SI alone, OSTA alone, BMD of the femoral neck, and BMD of the trochanter. The most noticeable result is that the combination of SI plus OSTA may be of clinical benefit when distinguishing between diabetic women with hip fracture versus without hip fracture. To be widely useful for a large population with T2DM, an assessment tool must be as simple as possible. The SI and OSTA are both simple, quick, and inexpensive risk assessment tools. The combination of SI plus OSTA could be especially useful in communities where DXA is costly and inaccessible.

BMD is widely used to determine bone mass and fracture risk in patients with risk factors for osteoporotic fractures. However, previous studies have reported conflicting data on BMD and the risk of osteoporosis in patients with T2DM [30]. In the current study, we showed that all BMD parameters were lower in patients with fracture than in those without fracture. The prevalence of osteoporosis was 66.7% in the fracture group and 41.4% in the control group, which also showed that osteoporosis was high in prevalence in the subjects with hip fracture. However, based on AUC analysis, BMD in the lumbar spine was superior to BMD in other regions in predicting hip fracture. BMD only explains 70 to 75% of the variance in bone strength; the macrogeometry of cortical bone and the microarchitecture of trabecular bone may be responsible for much of bone strength [3135]. For a given BMD, diabetic bone is more fragile and has a higher risk of fracture than non-diabetic bone [3638]. Some studies have indicated that material changes and structural abnormalities lead to increased bone fragility in patients with diabetes [3941]. The World Health Organization’s Fracture Risk Assessment Tool, which is designed to predict the 10-year probability of osteoporotic fracture based on femoral neck BMD and other clinical risk factors, has been shown to underestimate fracture risk in diabetic patients. Hence, T2DM presents specific challenges for fracture risk assessment.

Because it is expensive and time consuming, DXA is not available at every healthcare center. The SI is a simple method of assessing bone strength that can be used to assess osteoporosis without DXA. Previous studies have shown that SI provides a reliable estimate of mechanical bone quality in addition to bone mass of the proximal femur [4244]. In another study, Cemal et al. reported that the SI had relatively high specificity in predicting osteoporosis, but results were not consistent with those obtained with DXA because only bone loss beyond 30 to 50% can be present on plain radiographs [45]. In the present study, we adopted the Youden index to select an optimal cutoff threshold, which considered the balance between both sensitivity and specificity. The good performance is generally confirmed as AUC > 0.75. The best cutoff of OSTA and SI for predicting hip fracture were −2.5 and 2.5, respectively. It indicated further attention needed for high fracture risk. This study suggested that SI has a low predictive value (AUC 0.636) and sensitivity (42.5%), but good specificity (88.2%) in identifying hip fracture. SI alone was not an excellent predictive tool. Although the SI has shortcomings, it does have several advantages because it has good correlations with mechanical parameters of the trabecular bone of the proximal femur. In this study, we also evaluated the performance of the OSTA and found that the OSTA alone did not perform well in patients with diabetes. There was no significant difference in OSTA scores between the fracture group and control group. ROC analysis showed that the OSTA had a low predictive value (AUC 0.534, sensitivity 44.8%, specificity 73.8%, Fig. 2). Because the OSTA uses only age and weight as risk factors in its calculation, it can be distorted by obesity, which is widespread in T2DM. Overweight and obesity are generally believed to be protective factors for BMD through mechanical loading and hormonal factors, including insulin, estrogen, and leptin [46, 47]. Therefore, the OSTA index did not perform very well in identifying hip fracture in women with T2DM.

Fig. 2
The ROC curves for OSTA, SI, and combination of OSTA plus SI

The present study provides further evidence about the combined use of the OSTA plus SI in assessing fracture risk in patients with T2DM. The data confirmed that the combination of the OSTA plus SI had a high predictive value (AUC 0.795), which was significantly higher than other screening tools. Combining these two assessments clearly enhanced their predictive ability. The findings highlight the importance of incorporating both OSTA and SI scores. However, the risk factors for hip fracture are complicated in patients with diabetes. For example, patients with T2DM are more likely to fall, but little is known about the specific risk factors for falling, including impaired visual acuity from diabetic retinopathy, balance disorders from coexisting sensory motor neuropathy, and diabetic foot [48]. On the other hand, T2MD may affect bone metabolism. As a result of concurrent albuminuria or exaggerated renal excretion of vitamin D metabolites, the vitamin D insufficiency has been linked to patients with diabetes compared to the general population [49]. Biochemical markers of bone metabolism, such as serum C-terminal telopeptide of type I collagen (β-CTX) and serum N-amino terminal prepeptide of type 1 procollagen (P1NP) have been found to be associated with skeletal health in T2MD [7, 30]. At the same time, there remained many controversies regarding the underlying mechanisms for bone fragility affected by diabetes metabolism. Therefore, an assessment tool for hip fracture risk must be further developed for the diabetic population.

The major limitation of this study is that was a retrospective case-control study. Prospective studies are more appropriate for the prediction of incident fractures. Our results cannot directly confirm an association between the value of various parameters and osteoporotic hip fracture. However, we believe that this limitation had little effect on the results. Second, the sample size was relatively small and without random control. These characteristics could have affected the spread of the data, which should be further confirmed in other larger cohorts. Furthermore, the OSTA was developed particularly in Asian countries. This tool may need to be validated in other ethnics.

Conclusions

The combination of the OSTA plus SI could be useful for the clinical evaluation of hip fracture risk in women with T2DM, despite the paradox of fracture risk factors in this population. Considering that the OSTA and SI are the briefest and least expensive approaches to assessing bone health, a combination of the OSTA plus SI is suitable as a simple predictive tool in clinical practice to screen for hip fracture risk in a large diabetic population.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

Please contact the author for data requests.

Authors’ contributions

BJW conceived of the study and contributed to the critical revision of the article for important intellectual content. ZYL drafted the manuscript and evaluated the data. HG performed statistical expertise and evaluated the data. XDB collected and assembled the data. LZ helped with the data collection/interpretation. YDL participated in the coordination of the study and collected the data. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study was approved by the ethics committee of Beijing Friendship Hospital. All patients provided informed consent to participate in this study. This study was conducted in accordance with the latest version of the Declaration of Helsinki. Each subject was ensured anonymity, which was maintained by using subject-specific numeric codes on all records, including DXA scans and registration cards.

Abbreviations

AUC
Area under the receiver operating characteristic curve
BMD
Bone mineral density
BMI
Body mass index
DXA
Dual-energy X-ray absorptiometry
OSTA
Osteoporosis Self-Assessment Tool for Asians
ROC
Receiving operator curve
SI
Singh Index

Contributor Information

Zhenyu Liu, moc.361@sckgyyyyjb.

Hua Gao, moc.361@lyhzcod.

Xiaodong Bai, moc.361@gnidienius.

Liang Zhao, moc.361@jxwhsf.

Yadong Li, moc.361@gnahsgnauhcekug.

Baojun Wang, Phone: (086)01063139264, moc.liamtoh@lyhzcod.

References

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53. doi: 10.2337/diacare.27.5.1047. [PubMed] [Cross Ref]
2. Janghorbani M, Feskanich D, Willett WC, Hu F. Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care. 2006;29(7):1573–8. doi: 10.2337/dc06-0440. [PubMed] [Cross Ref]
3. Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care. 2007;30(4):835–41. doi: 10.2337/dc06-1851. [PubMed] [Cross Ref]
4. Melton LJ, 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008;23(8):1334–42. doi: 10.1359/jbmr.080323. [PMC free article] [PubMed] [Cross Ref]
5. Nicodemus KK, Folsom AR. Iowa Women’s Health S. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001;24(7):1192–7. doi: 10.2337/diacare.24.7.1192. [PubMed] [Cross Ref]
6. Hosoda H, Fukui M, Nakayama I, Asano M, Kadono M, Hasegawa G, et al. Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus. Metabolism. 2008;57(7):940–5. doi: 10.1016/j.metabol.2008.02.009. [PubMed] [Cross Ref]
7. Zhou Y, Li Y, Zhang D, Wang J, Yang H. Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract. 2010;90(3):261–9. doi: 10.1016/j.diabres.2010.09.013. [PubMed] [Cross Ref]
8. Ma L, Oei L, Jiang L, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012;27:319–32. doi: 10.1007/s10654-012-9674-x. [PMC free article] [PubMed] [Cross Ref]
9. Jackuliak P, Payer J. Osteoporosis, fractures, and diabetes. Int J Endocrinol. 2014;2014:820615. doi: 10.1155/2014/820615. [PMC free article] [PubMed] [Cross Ref]
10. Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2012;27:301–8. doi: 10.1002/jbmr.556. [PubMed] [Cross Ref]
11. Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305:2184–92. doi: 10.1001/jama.2011.715. [PMC free article] [PubMed] [Cross Ref]
12. Singh M, Nagrath AR, Maini PS. Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am. 1970;52(3):457–67. doi: 10.2106/00004623-197052030-00005. [PubMed] [Cross Ref]
13. Krischak GD, Augat P, Wachter NJ, Kinzl L, Claes LE. Predictive value of bone mineral density and Singh index for the in vitro mechanical properties of cancellous bone in the femoral head. Clin Biomechanics. 1999;14(5):346–51. doi: 10.1016/S0268-0033(98)90095-X. [PubMed] [Cross Ref]
14. Wachter NJ, Augat P, Hoellen IP, Krischak GD, Sarkar MR, Mentzel M, et al. Predictive value of Singh index and bone mineral density measured by quantitative computed tomography in determining the local cancellous bone quality of the proximal femur. Clin Biomechanics. 2001;16(3):257–62. doi: 10.1016/S0268-0033(00)00093-0. [PubMed] [Cross Ref]
15. Soontrapa S, Soontrapa S. Modified Singh index in diagnosing femoral neck osteoporosis. J Med Assoc Thai. 2011;94(Suppl 5):S79–83. [PubMed]
16. Patel SH, Murphy KP. Fractures of the proximal femur: correlates of radiological evidence of osteoporosis. Skeletal Radiol. 2006;35(4):202–11. doi: 10.1007/s00256-005-0065-1. [PubMed] [Cross Ref]
17. Hauschild O, Ghanem N, Oberst M, Baumann T, Kreuz PC, Langer M, et al. Evaluation of Singh index for assessment of osteoporosis using digital radiography. Eur J Radiol. 2009;71(1):152–8. doi: 10.1016/j.ejrad.2008.03.019. [PubMed] [Cross Ref]
18. Yamamoto M. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength. Endocr J. 2015;62:299–308. [PubMed]
19. Leslie WD, Aubry-Rozier B, Lamy O, Hans D, Manitoba Bone Density Program. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab. 2013;98(2):602-9. [PubMed]
20. Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12(8):699–705. doi: 10.1007/s001980170070. [PubMed] [Cross Ref]
21. Geusens P, Hochberg MC, van der Voort DJ, Pols H, van der Klift M, Siris E, et al. Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc. 2002;77(7):629–37. doi: 10.4065/77.7.629. [PubMed] [Cross Ref]
22. Cadarette SM, McIsaac WJ, Hawker GA, Jaakkimainen L, Culbert A, Zarifa G, et al. The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int. 2004;15(5):361–6. doi: 10.1007/s00198-003-1552-7. [PubMed] [Cross Ref]
23. Kung AW, Ho AY, Sedrine WB, Reginster JY, Ross PD. Comparison of a simple clinical risk index and quantitative bone ultrasound for identifying women at increased risk of osteoporosis. Osteoporos Int. 2003;14:716–21. doi: 10.1007/s00198-003-1428-x. [PubMed] [Cross Ref]
24. Park HM, Sedrine WB, Reginster JY, Ross PD. Osta. Korean experience with the OSTA risk index for osteoporosis: a validation study. J Clin Densitom. 2003;6(3):247–50. doi: 10.1385/JCD:6:3:247. [PubMed] [Cross Ref]
25. Yang NP, Lin T, Wang CS, Chou P. Correlation of osteoporosis screening by quantitative ultrasound of calcaneus and Osteoporosis Self-Assessment Tool for Asians in Taiwanese. J Formos Med Assoc. 2004;103(2):130–6. [PubMed]
26. Tao B, Liu JM, Li XY, Wang JG, Wang WQ, Ning G. An assessment of the use of quantitative ultrasound and the Osteoporosis Self-Assessment Tool for Asians in determining the risk of nonvertebral fracture in postmenopausal Chinese women. J Bone Miner Metab. 2008;26(1):60–5. doi: 10.1007/s00774-007-0798-0. [PubMed] [Cross Ref]
27. Saetung S, Ongphiphadhanakul B, Rajatanavin R. The relationship of an Asian-specific screening tool for osteoporosis to vertebral deformity and osteoporosis. J Bone Miner Metab. 2008;26(1):47–52. doi: 10.1007/s00774-007-0796-2. [PubMed] [Cross Ref]
28. Chen SJ, Chen YJ, Cheng CH, Hwang HF, Chen CY. Lin MR Comparisons of Different Screening Tools for Identifying Fracture/Osteoporosis Risk Among Community-Dwelling Older People. Medicine (Baltimore) 2016;95(20):e3415. doi: 10.1097/MD.0000000000003415. [PMC free article] [PubMed] [Cross Ref]
29. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–9. doi: 10.1007/s00198-004-1780-5. [PubMed] [Cross Ref]
30. Jiajue R, Jiang Y, Wang O, Li M, Xing X, Cui L, et al. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporos Int. 2014;25:1999–2005. doi: 10.1007/s00198-014-2714-5. [PubMed] [Cross Ref]
31. Wachter NJ, Augat P, Krischak GD, Mentzel M, Kinzl L, Claes L. Prediction of cortical bone porosity in vitro by microcomputed tomography. Calcif Tissue Int. 2001;68(1):38–42. doi: 10.1007/BF02685001. [PubMed] [Cross Ref]
32. Sanyal A, Gupta A, Bayraktar HH, Kwon RY, Keaveny TM. Shear strength behavior of human trabecular bone. J Biomech. 2012;45(15):2513–9. doi: 10.1016/j.jbiomech.2012.07.023. [PMC free article] [PubMed] [Cross Ref]
33. Link TM, Majumdar S. Current diagnostic techniques in the evaluation of bone architecture. Curr Osteoporos Rep. 2004;2(2):47–52. doi: 10.1007/s11914-004-0003-5. [PubMed] [Cross Ref]
34. Rubin CD. Emerging concepts in osteoporosis and bone strength. Curr Med Res Opin. 2005;21(7):1049–56. doi: 10.1185/030079905X50525. [PubMed] [Cross Ref]
35. Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J Endocrinol Invest. 2004;27(1):99–105. doi: 10.1007/BF03350919. [PubMed] [Cross Ref]
36. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001;86(1):32–8. doi: 10.1210/jcem.86.1.7139. [PubMed] [Cross Ref]
37. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med. 2005;165(14):1612–7. doi: 10.1001/archinte.165.14.1612. [PubMed] [Cross Ref]
38. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int. 2007;18(4):427–44. doi: 10.1007/s00198-006-0253-4. [PubMed] [Cross Ref]
39. Leslie WD, Rubin MR, Schwartz AV, Kanis JA. Type 2 diabetes and bone. J Bone Miner Res. 2012;27(11):2231–7. doi: 10.1002/jbmr.1759. [PubMed] [Cross Ref]
40. Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(11):5045–55. doi: 10.1210/jc.2010-0226. [PubMed] [Cross Ref]
41. Garg R, Chen Z, Beck T, Cauley JA, Wu G, Nelson D, et al. Hip geometry in diabetic women: implications for fracture risk. Metabolism. 2012;61(12):1756–62. doi: 10.1016/j.metabol.2012.05.010. [PMC free article] [PubMed] [Cross Ref]
42. Barondess DA, Singh M, Hendrix SL, Nelson DA. Radiographic measurements, bone mineral density, and the Singh Index in the proximal femur of white and black postmenopausal women. Dis Mon. 2002;48(10):637–46. doi: 10.1053/cjwh.2001.30067. [PubMed] [Cross Ref]
43. Soontrapa S, Soontrapa S, Srinakarin J, Chowchuen P. Singh index screening for femoral neck osteoporosis. J Med Assoc Thai. 2005;88(Suppl 5):S13–6. [PubMed]
44. Trijoto I, Isbagio H, Setiyohadi B, Soegondo S, Kusumawidjaja K, Ariawan I. The diagnostic value of combined risk factor analysis and radiological imaging in determining osteoporosis in post-menopausal women. Acta Med Indones. 2005;37(1):26–32. [PubMed]
45. Bes C, Güven M, Akman B, Atay EF, Ceviz E, Soy M. Can bone quality be predicted accurately by Singh index in patients with rheumatoid arthritis? Clin Rheumatol. 2012;31(1):85–9. doi: 10.1007/s10067-011-1786-2. [PubMed] [Cross Ref]
46. Barrera G, Bunout D, Gattás V, de la Maza MP, Leiva L, Hirsch S. A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition. 2004;20(9):769–71. doi: 10.1016/j.nut.2004.05.014. [PubMed] [Cross Ref]
47. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993;8(5):567–73. doi: 10.1002/jbmr.5650080507. [PubMed] [Cross Ref]
48. Maurer MS, Burcham J, Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-termcare facility. J Gerontol A Biol Sci Med Sci. 2005;60(9):1157–62. doi: 10.1093/gerona/60.9.1157. [PubMed] [Cross Ref]
49. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2010;64(3):351–5. doi: 10.1111/j.1742-1241.2009.02221.x. [PubMed] [Cross Ref]

Articles from Journal of Orthopaedic Surgery and Research are provided here courtesy of BioMed Central